Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT05685810

Genetic Determinants of Kidney Disease in People of African Ancestry With HIV

Conditions: HIV Nephropathy, Kidney Injury, Kidney Diseases, Diabetes Mellitus, Obesity, Cardiovascular Diseases, Genetic Predisposition to Disease

Sex: All
Ages: 18 Years – N/A
Enrollment: 3029
Sponsor: King's College Hospital NHS Trust

Location: United Kingdom

Summary

Black ethnicity is a major risk factor for chronic kidney disease [CKD] in people with HIV infection, suggesting that genetic factors are an important determinant of kidney disease progression in this population. The Gen-Africa study was established in 2018 to allow the study of genetic and clinical risk factors for CKD in people with HIV in the UK. Just over 3000 people across 15 sites were enrolled between May 2018 and January 2020. Demographic and clinical information was collected, and biological samples (buffy coats, plasma and urine) obtained. Cross-sectional analyses have revealed that participants of West-African ancestry are at higher risk of CKD and end-stage kidney disease [ESKD], and that genetic variants in the apolipoprotein L1 (APOL1) gene and sickle cell trait (SCT) are predictors of CKD and ESKD. The pathogenesis of APOL1- and SCT-associated CKD is incompletely understood, and additional, longitudinal data will be collected to improve understanding of the contribution of demographic, traditional CKD (diabetes, hypertension, obesity/metabolic syndrome, cardiovascular disease) and HIV (immuno-virological and hepatitis B/C co-infection status, antiretroviral medications) risk factors as well as additional genetic and epigenetic markers.

Eligibility Criteria

Inclusion Criteria:HIV positiveBlack ethnicity (self-identified)Informed consentExclusion Criteria:None

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05685810). StuddyBuddy aggregates publicly available trial information.